Clinical trial
The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery
NCT00122720 · Herning Hospital, Other · Completed
Key facts
| NCT number | NCT00122720 |
|---|---|
| Title | The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery |
| Official title | The Effect of Darbepoetin Alfa Treatment Upon the Rehabilitation Following Planned Surgery for Colorectal Cancer |
| Lead sponsor | Herning Hospital, Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa |
| Enrollment | 200 |
| Start date | Jun 1, 2003 |
| Completion | Jan 1, 2006 |
| First posted | Jul 22, 2005 |
| Last update posted | Jul 7, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: